Se-Methyl-Seleno-L- Cysteine (MSC) in Treating Healthy Patients

Status Completed

Clinical Trial Summary

This randomized phase I trial is studying the side effects and best dose of Se-methyl-seleno-L-cysteine in healthy adult men. Studying samples of blood, urine, and toenail clippings in the laboratory from healthy men receiving Se-methyl-seleno-L-cysteine may help doctors learn more about how Se-methyl-seleno-L-cysteine works in the body.

Clinical Trial Description

PRIMARY OBJECTIVES:

I. To evaluate the toxicity of MSC, given to healthy adult males as a single oral dose.

SECONDARY OBJECTIVES:

I. To characterize the pharmacokinetics of single oral doses of MSC in healthy adult male volunteers.

II. To evaluate the baseline selenium content of toenail clippings in healthy adult males.

OUTLINE: This is a multicenter, randomized, placebo controlled, double blind, dose escalation study. Participants are randomized to 1 of 2 arms.

Arm I: Participants receive oral placebo on day 1.

Arm II: Participants receive oral Se-methyl-seleno-l-cysteine (MSC) on day 1. Cohorts of 5 participants receive escalating doses of MSC until the maximum tolerated dose (MTD) is determined. The MTD is defined as the dose preceding that at which 2 of 5 or 2 of 10 patients experience dose-limiting toxicity.

Participants undergo blood, urine, and toenail clipping collection for pharmacokinetic and correlative studies. Samples are analyzed for plasma protein levels of selenium for proteomic and gene expression, molecular fingerprinting by mass spectrometry, and RNA by gene array analysis.

After completion of study treatment, participants are followed at 7-14 days and at 30 days. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention

Related Conditions & MeSH terms

Healthy, no Evidence of Disease

Clinical Trial Details

NCT number	NCT00489372
Study type	Interventional
Source	National Cancer Institute (NCI)
Contact
Status	Completed
Phase	Phase 1
Start date	July 2007
Completion date	July 2009

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01950403` - Linaclotide Acetate in Preventing Colorectal Cancer in Healthy Volunteers	Phase 1
Terminated	`NCT01561989` - Cholecalciferol and Flu Vaccine in Treating Healthy Participants	N/A
Terminated	`NCT01336387` - Dose-Finding of Retinoid 9cUAB30 in Healthy Volunteers	Phase 1
Completed	`NCT01140646` - Evaluation of SAMe for Hot Flashes	Phase 2
Completed	`NCT00892515` - Exercise Programs in Healthy Young Women at Increased Risk of Developing Breast Cancer	N/A
Completed	`NCT00450957` - Lycopene in Healthy Male Participants	Phase 1
Completed	`NCT00365209` - Phase II A Trial of Curcumin Among Patients With Prevalent Subclinical Neoplastic Lesions (Aberrant Crypt Foci)	Phase 2
Recruiting	`NCT04445532` - Hepatobiliary Tumors Tissue Samples Acquisition
Completed	`NCT02100254` - Narrative or Fact-Based Videos in Increasing Colorectal Cancer Screenings in African American Communities	N/A
Completed	`NCT02129517` - Web-Based Tailored Educational Program in Improving Nurse Communication With Patients About Clinical Trials	N/A
Terminated	`NCT01755208` - Light-Scattering Spectroscopy for Detection of Breast Cancer	N/A
Completed	`NCT00499460` - Effects of Garlic Supplements on Opioids in Healthy Volunteers	Phase 4
Completed	`NCT00392652` - Diindolylmethane in Healthy Volunteers	Phase 1
Completed	`NCT01077453` - Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer	Phase 1
Completed	`NCT00478309` - Genetic Epidemiology Risk Assessment Program or Usual Care in Colorectal Cancer Screening for Healthy Participants	N/A
Completed	`NCT01370889` - Resveratrol in Postmenopausal Women With High Body Mass Index	Phase 1
Completed	`NCT00896207` - Studying Different Formulations of SR13668 in Healthy Volunteers	Phase 1
Completed	`NCT00679094` - Bowman-Birk Inhibitor Concentrate in Healthy Men	Phase 1
Terminated	`NCT02154984` - Time Restricted Diet in Obese or Overweight Pre or Postmenopausal Participants	N/A
Completed	`NCT00513916` - Effect of Dietary Soy on Estrogens in Breast Fluid, Blood, and Urine Samples From Healthy Women	Phase 3